Filing Details
- Accession Number:
- 0001179110-11-014795
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-03 17:12:30
- Reporting Period:
- 2011-09-08
- Filing Date:
- 2011-11-03
- Accepted Time:
- 2011-11-03 17:12:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1391823 | L Edward Michael | 100 Abbott Park Road Abbott Park IL 60064-6400 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares Without Par Value | Disposition | 2011-09-08 | 5,000 | $0.00 | 214,865 | No | 5 | G | Direct | |
| Common Shares Without Par Value | Acquisiton | 2011-11-01 | 42,561 | $41.03 | 257,426 | No | 4 | M | Direct | |
| Common Shares Without Par Value | Acquisiton | 2011-11-01 | 10,640 | $40.99 | 268,066 | No | 4 | M | Direct | |
| Common Shares Without Par Value | Disposition | 2011-11-01 | 45,530 | $53.87 | 222,536 | No | 4 | F | Direct | |
| Common Shares Without Par Value | Disposition | 2011-11-01 | 4,800 | $53.24 | 217,736 | No | 4 | S | Direct | |
| Common Shares Without Par Value | Disposition | 2011-11-01 | 2,286 | $53.24 | 215,450 | No | 4 | S | Direct | |
| Common Shares Without Par Value | Disposition | 2011-11-01 | 8,000 | $53.10 | 207,450 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Option (right to buy) | Disposition | 2011-11-01 | 42,561 | $0.00 | 42,561 | $41.03 |
| Common Shares | Option (right to buy) | Disposition | 2011-11-01 | 10,640 | $0.00 | 10,640 | $40.99 |
| Common Shares | Option (right to buy) | Acquisiton | 2011-11-01 | 36,379 | $0.00 | 36,379 | $53.87 |
| Common Shares | Option (right to buy) | Acquisiton | 2011-11-01 | 9,151 | $0.00 | 9,151 | $53.87 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2007-02-20 | 2014-02-19 | No | 4 | M | Direct |
| 0 | 2006-07-15 | 2013-07-14 | No | 4 | M | Direct |
| 36,379 | 2012-05-01 | 2014-02-19 | No | 4 | A | Direct |
| 9,151 | 2012-05-01 | 2013-07-14 | No | 4 | A | Direct |
Footnotes
- Transaction made pursuant to a previously adopted plan complying with Rule 10b5-1(c).
- Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.
Billionaire Hedge Funds
